🔎 Trials Near Me

Home › Plasmablastic Lymphoma

Plasmablastic Lymphoma clinical trials recruiting in the U.S.

5 studies for Plasmablastic Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07332507

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 25, 2026 · NCT05389423

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT04139304

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502

Study of SGR-1505 in Mature B-Cell Neoplasms

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.